PDGF regulated migration of mesenchymal stem cells towards malignancy acts via the PI3K signaling pathway

Issue title: Selected papers from the Neubrandenburg Conference, 8-9 June, 2018

Article type: Research Article

Authors: Salha, Sonia^{a; c} | Gehmert, Sebastian^{b; c; *} | Brébant, Vanessa^{c; d} | Anker, Alexandra^{c; d} | Loibl, Markus^{c; e} | Prantl, Lukas^{c; d} | Gehmert, Sanga^{c; f}

Affiliations: [a] Department of Orthopedics and Traumatology, University Hospital Basel, Switzerland | [b] Department of Orthopedics, University Children’s Hospital Basel, Switzerland | [c] Applied Stem Cell Research Center, University Medical Center Regensburg, Germany | [d] Department of Plastic, Hand-and Reconstructive Surgery, University Medical Center Regensburg, Germany | [e] Department of Trauma Surgery, Regensburg University Medical Center, Regensburg, Germany | [f] Department of Gynecology and Obstetrics, Kantonsspital Baselland, Liestal, Switzerland

Correspondence: [*] Corresponding author: Sebastian Gehmert, Department of Orthopedics, University Children’s Hospital Basel, Spitalstrasse 33, 4031 Basel, Switzerland. E-mail: s.gehmert@gmail.com.

Abstract: INTRODUCTION:Mesenchymal stem cells (MSCs) have been described in breast cancer models to migrate towards carcinoma and integrate into tumor associated stroma supporting tumor growth, increasing their metastatic potency and contributing to tumor-angiogenesis. Platelet-derived growth factor (PDGF) isoforms (AA, BB, CC) stimulate growth, survival and motility of MSCs and certain other cell types. Noteworthy, breast carcinomas are known to express PDGF. We aim to further shed light on i) the relevance of the different PDGF isoforms on adipose tissue derived stem cells (ASCs) migration and ii) the underlying pathway dependent on PDGF stimulation. MATERIALS AND METHODS:Breast cancer cell lines were purchased and ASC’s were isolated from murine subcutaneous adipose tissue. The transmigration of ASC’s towards the PDGF-isoforms was assessed by using recombinant human PDGF-AA, PDGF-BB and PDGF-CC in a trans-well culture dish system. Transmigrated ASC’s were quantified in 5 randomly selected fields per condition using fluorescence microscopy after calcein-staining. PDGF-BB depended transmigration of ASC’s was verified by downregulation and overexpression of PDGF-BB in breast cancer cell line using lentiviral vectors. In addition, a PI3-kinase inhibitor (LY294002) and a MAP-kinase inhibitor (PD98059) were used to identify the pathway involved in the PDGF-BB mediated migration of ASC’s towards tumor. RESULTS:ASC’s transmigration significantly increased towards PDGF AA at 50 ng and only showed further increase by 500 ng which was similar to cell behavior when exposed to PDGF CC. In comparison, PDGF-BB significantly increased ASC’s transmigration already at a low level of 5 ng with further significant increase for 20 ng and 40 ng. Cell transmigration was blocked with PDGFR-α antibodies but only for PDGF-AA and PDGF-CC whereas PDGFR-β blockage showed a significant effect on transmigration for PDGF-BB and PDGF-CC but not for PDGF-AA. Neutralizing antibodies in combination with PDGF receptor blockage confirmed findings. In addition, only PI3-kinase inhibitor but not the MEK-1 selective inhibitor caused a significant decrease of transmigration for ASCs towards breast cancer cells. DISCUSSION:The transmigration of ASC’s is most significantly enhanced by PDGF-BB via the PI3-kinase pathway. This data support that PI3-kinase is an important key player for MSC migration towards malignancy which need further research to prevent tumor progression in early disease stage.

Keywords: Mesenchymal stem cells, migration, breast cancer, PDGF-BB, PI3K pathway

DOI: 10.3233/CH-189319

Journal: Clinical Hemorheology and Microcirculation, vol. 70, no. 4, pp. 543-551, 2018